Search Results

Displaying Results 3476-3500 of 4069 "'SKIN'"

Nov 25, 2025, 08:00 ET Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting

common type of cutaneous lymphoma. In CTCL, T-cells, a type of lymphocyte that plays a role in the immune system, become cancerous and develop into skin lesions, leading to a decrease in the quality of life of patients with this disease due to severe pain and pruritus. Mycosis Fungoides (MF) and Sézary

More news about: Citius Oncology, Inc.


Nov 25, 2025, 06:59 ET Pet Biotics Market worth $1,232.5 million by 2030- Exclusive Report by MarketsandMarkets™

solutions are creating strong opportunities for innovative biotic ingredients that enhance stability, efficacy, and targeted benefits, such as improved skin health, stress reduction, and enhanced nutrient absorption.Browse in-depth TOC on "Pet Biotics Market"250– Tables50–

More news about: MarketsandMarkets


Nov 25, 2025, 05:01 ET Generic Drugs Market Size to Worth USD 898 Billion by 2035, at a CAGR of 5.75% | Research by Vantage Market Research

complexity.Topical: Topical generics including creams, gels, ointments, and dermatology formulations are experiencing rising demand due to increasing cases of skin disorders, infections, and chronic dermatologic conditions. Growth is also supported by improved manufacturing of semi-solid formulations and faster

More news about: Vantage Market Research


Nov 25, 2025, 04:53 ET Menarini Group anuncia nuevos datos sobre ELZONRIS® (tagraxofusp-erzs)

Favorable outcomes including post-transplant survival are seen independent  of baseline skin burden in treatment-naïve patients (pts) with blastic  plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup

More news about: Menarini Industrie Farmaceutiche Riunite


Nov 25, 2025, 04:44 ET 메나리니 그룹, 제67회 미국혈액학회 연례 학술대회에서 ELZONRIS®(tagraxofusp-erzs) 관련 신규 데이터 발표

환자에서 기저 피부 병변 부담과 무관하게 이식 후 생존을 포함한 우수한 결과 확인: 주요 임상시험의 하위 그룹 분석(Favorable outcomes including post-transplant survival are seen independent of baseline skin burden in treatment-naïve patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup analysis

More news about: Menarini Industrie Farmaceutiche Riunite


Nov 25, 2025, 02:33 ET RefluxStop® 'Best in Class' at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons

communicate to the caregiver on distance and a wireless energizing platform designed to power remote-controlled implants wirelessly through intact skin. Implantica is listed on Nasdaq First North Premier Growth Market (ticker: IMP A SDB). Visit www.implantica.com

More news about: Implantica


Nov 24, 2025, 17:56 ET Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

undergo regular blood tests to monitor liver function.Patients and caregivers should contact the patient's doctor immediately if the patient's skin and/or whites of the eyes become yellowish, if the patient misses a dose of corticosteroid or vomits it up, or if the patient experiences a decrease

More news about: Novartis


Nov 24, 2025, 16:47 ET UTulsa named a 2026 top school for entrepreneurs

entrepreneurship in the U.S.," said UTulsa's Center for Innovation & Entrepreneurship Director Chris Wright. "Whether creating novel technologies to detect skin cancer, digitizing receipts and transactions or developing novel processes to create renewable hydrogen energy, our student and alumni founders are

More news about: The University of Tulsa


Nov 24, 2025, 12:59 ET BOROUX Launches Advanced Shower Filter System

Removes 98% of Chlorine for Healthier Hair and SkinPUEBLO, Colo., Nov. 24, 2025 /PRNewswire/ -- BOROUX, a leader in premium water‑filtration solutions, announces the official launch of its BOROUX

More news about: BOROUX


Nov 24, 2025, 12:00 ET Merck Manuals Answers Common Questions About Age-Related Macular Degeneration

and most vital area of the retina. As people get older, they can develop spots on the macula known as drusen, which are similar to age spots on the skin. As a result, central vision becomes washed out and loses detail, and straight lines may appear wavy.What is the difference between dry and

More news about: The Merck Manuals


Nov 24, 2025, 12:00 ET Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting

Jaypirca. Second Primary Malignancies: Second primary malignancies, including non-skin carcinomas, developed in 9% of Jaypirca-treated patients. The most frequent malignancy was non-melanoma skin cancer (4.6%). Other second primary malignancies included solid tumors (including genitourinary

More news about: Eli Lilly and Company


Nov 24, 2025, 11:39 ET Aesthetic Fillers Market Surges to USD 8.45 Billion by 2033, Propelled by 7.2% CAGR - Verified Market Reports®

plans.Product innovation — next-gen hyaluronic & bioactive blends: Formulation advances (longer persistence, integrated biostimulatory chemistry, skin-boosters) are enabling expanded indications beyond cosmetics into minimally invasive restorative therapies. This widens TAM and justifies premium ASPs.Channel

More news about: Verified Market Reports


Nov 24, 2025, 11:04 ET CellRegen Lab Launches in Boca Raton with Exclusive Human Regenerator Jet Bed Inside Essentia Wellness Facility

reduces inflammation, oxidative stress, and supports better circulation.Improves skin, hair, and nail health.

More news about: CellRegen Lab


Nov 24, 2025, 10:27 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

aggressive, orphan hematologic malignancy that primarily affects skin, bone marrow and blood. It can also affect other parts of the body, such as the lymph nodes, spleen, liver and central nervous system. Approximately 85% to 90% of patients develop skin lesions as a first sign of BPDCN. BPDCN affects all people

More news about: Menarini Industrie Farmaceutiche Riunite


Nov 24, 2025, 10:20 ET Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

aggressive, orphan hematologic malignancy that primarily affects skin, bone marrow and blood. It can also affect other parts of the body, such as the lymph nodes, spleen, liver and central nervous system. Approximately 85% to 90% of patients develop skin lesions as a first sign of BPDCN. BPDCN affects all people

More news about: Menarini Industrie Farmaceutiche Riunite


Nov 24, 2025, 09:30 ET Maybelline Reunites Lacey Chabert & Dustin Milligan in New 5-Part Microdrama: "Maybe This Christmas"

effortless blendability. With buildable medium-to-full coverage and a natural, skin-like finish, the formula offers up to 12 hours of comfortable wear. It's crease-resistant, non-comedogenic, and suitable for a wide range of skin types.To watch the 'Maybe This Christmas' trailer and the full microdrama

More news about: Maybelline New York


Nov 24, 2025, 09:00 ET Milan Laser Hair Removal Appoints New Executive Leadership to Drive Expansion of Its 400+ Clinics Across the U.S.

laser hair removal, medically trained and board-certified staff, use of the gold-standard Candela GentleMax Pro laser with customized treatments for all skin types, and a lifetime guarantee via The Unlimited Package™. Milan offers laser hair removal across full-body, face, bikini, underarms and men's areas,

More news about: Milan Laser


Nov 24, 2025, 09:00 ET Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

precision dermatology. Azitra's lead program, ATR-12, uses an engineered strain of S. epidermidis designed to treat Netherton syndrome, a rare, chronic skin disease with no approved treatment options. Netherton syndrome may be fatal in infancy with those living beyond a year having profound lifelong challenges.

More news about: Azitra, Inc.


Nov 24, 2025, 07:30 ET Shapeshifting cancers' masters, unmasked

behave like other malignancies. Some of these tumors act as shapeshifters and start to resemble cells from other organs of the human body, such as skin. This bizarre behavior presents a challenge for existing therapies. "The tumors are notoriously plastic in their cellular identity," says Cold Spring

More news about: Cold Spring Harbor Laboratory


Nov 24, 2025, 05:00 ET More Muscle, Less Belly Fat Slows Brain Aging

artificial intelligence (AI) algorithm was used to quantify total normalized muscle volume, visceral fat (hidden belly fat), subcutaneous fat (fat under the skin) and brain age.The researchers found that a higher visceral fat to muscle ratio was associated with higher brain age, while subcutaneous fat showed

More news about: Radiological Society of North America (RSNA)


Nov 23, 2025, 11:19 ET The Future of Aesthetic Surgery Lands in L.A.: Defyne Plastic Surgery Expands to West Coast in 2026

Tuck: A contouring technique intended to provide definition with reduced downtime.Regenerative Nanofat Therapy: A treatment designed to support skin quality and underlying tissue vitality.Defyne's Los Angeles location will be led by Dr. David Mok, a board-certified plastic surgeon from Canada.

More news about: Defyne Plastic Surgery


Nov 23, 2025, 08:00 ET JOVS Launches the World's First and Only FDA-Cleared Laser Mask, Disrupting the Red Light Therapy Industry

firmness and more resilient skin.Week 2: 78.4% experienced visible lifting and contour enhancement, including a 9.58% increase in elasticity and 7.65% boost in firmness.Week 4: 91.9% achieved significant tightening and overall skin revitalization, supported

More news about: JOVS


Nov 22, 2025, 12:00 ET ModuleMD Showcases Advanced AI-Driven Allergy Solutions at ACAAI 2025

objective, standardized data to guide treatment decisions with confidence.SkinSight AI activates the moment a provider orders and administers a skin test panel. Once the panel is placed, the system analyzes a captured image and automatically detects all positive reactions, providing precise wheal

More news about: ModuleMD Healthcare Solutions Private Limited


Nov 21, 2025, 13:30 ET HMP Global Acquires Music City SCALE to Build the Industry's Most Comprehensive Learning Ecosystem in Aesthetic Medicine and Skin Health

aesthetic medicine, medical dermatology, and regenerative skin health. The acquisition closely follows the company's recent purchase of Masterclasses in Dermatology in April and further strengthens its position as the most comprehensive provider of skin health education. Terms of the transaction were not disclosed.A

More news about: HMP Global


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.